BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1490421)

  • 1. Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system.
    Edwardson JA; Candy JM; Ince PG; McArthur FK; Morris CM; Oakley AE; Taylor GA; Bjertness E
    Ciba Found Symp; 1992; 169():165-79; discussion 179-85. PubMed ID: 1490421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure.
    Candy JM; McArthur FK; Oakley AE; Taylor GA; Chen CP; Mountfort SA; Thompson JE; Chalker PR; Bishop HE; Beyreuther K
    J Neurol Sci; 1992 Feb; 107(2):210-8. PubMed ID: 1564520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.
    Harrington CR; Wischik CM; McArthur FK; Taylor GA; Edwardson JA; Candy JM
    Lancet; 1994 Apr; 343(8904):993-7. PubMed ID: 7909090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms.
    Armstrong RA; Winsper SJ; Blair JA
    Dementia; 1996; 7(1):1-9. PubMed ID: 8788075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy.
    Reusche E
    Acta Neuropathol; 1997 Dec; 94(6):612-6. PubMed ID: 9444364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.
    Wischik CM; Harrington CR; Mukaetova-Ladinska EB; Novak M; Edwards PC; McArthur FK
    Ciba Found Symp; 1992; 169():268-93; discussion 293-302. PubMed ID: 1490426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminium, amyloid, and Alzheimer's disease.
    Mera SL
    Med Lab Sci; 1991 Oct; 48(4):283-95. PubMed ID: 1811120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuropathology of Williams syndrome. Report of a 35-year-old man with presenile beta/A4 amyloid plaques and neurofibrillary tangles.
    Golden JA; Nielsen GP; Pober BR; Hyman BT
    Arch Neurol; 1995 Feb; 52(2):209-12. PubMed ID: 7848137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of aluminium in neuritic plaque cores in Alzheimer's disease.
    Landsberg JP; McDonald B; Watt F
    Nature; 1992 Nov; 360(6399):65-8. PubMed ID: 1436075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer beta-amyloid peptides: normal and abnormal localization.
    Takahashi RH; Nam EE; Edgar M; Gouras GK
    Histol Histopathol; 2002 Jan; 17(1):239-46. PubMed ID: 11813874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any relationship between aluminum and Alzheimer's disease?
    Eichhorn GL
    Exp Gerontol; 1993; 28(4-5):493-8. PubMed ID: 8224045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles.
    Lippa CF; Hamos JE; Smith TW; Pulaski-Salo D; Drachman DA
    Arch Neurol; 1993 Oct; 50(10):1088-92. PubMed ID: 8215968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.